Bonsel G - Search Results

1

Reporting format for economic evaluation. Part II: Focus on modelling studies.

Nuijten MJ, Pronk MH, Brorens MJ, Hekster YA, Lockefeer JH, de Smet PA, Bonsel G, van der Kuy A. Nuijten MJ, et al. Among authors: bonsel g. Pharmacoeconomics. 1998 Sep;14(3):259-68. doi: 10.2165/00019053-199814030-00003. Pharmacoeconomics. 1998. PMID: 10186465

2

Reporting format for economic evaluation. Part I: Application to the Dutch healthcare system.

Nuijten MJ, Brorens MJ, Hekster YA, van der Kuy A, Lockefeer JH, de Smet PA, Bonsel G, Pronk MH. Nuijten MJ, et al. Among authors: bonsel g. Pharmacoeconomics. 1998 Aug;14(2):159-63. doi: 10.2165/00019053-199814020-00004. Pharmacoeconomics. 1998. PMID: 10186456

3

Introduction to the pharmacoeconomics of herbal medicines.

De Smet PA, Bonsel G, Van der Kuy A, Hekster YA, Pronk MH, Brorens MJ, Lockefeer JH, Nuijten MJ. De Smet PA, et al. Among authors: bonsel g. Pharmacoeconomics. 2000 Jul;18(1):1-7. doi: 10.2165/00019053-200018010-00001. Pharmacoeconomics. 2000. PMID: 11010600

4

[Evaluation of drugs: efficacy, applicability, effectiveness and efficiency].

Pronk MH, Bonsel GJ, Brorens MJ, Hekster YA, van der Kuy A, de Smet PA. Pronk MH, et al. Among authors: bonsel gj. Ned Tijdschr Geneeskd. 1998 Mar 28;142(13):697-701. Ned Tijdschr Geneeskd. 1998. PMID: 9623142 Review. Dutch.

5

[The budget control function of the Drug Reimbursement System].

Pronk MH, Bonsel GJ, van der Kuy A. Pronk MH, et al. Among authors: bonsel gj. Ned Tijdschr Geneeskd. 2002 Sep 14;146(37):1729-33. Ned Tijdschr Geneeskd. 2002. PMID: 12357873 Review. Dutch.

6

Out-patient drug policy by clinical assessment rather than financial constraints? The gate-keeping function of the out-patient drug reimbursement system in The Netherlands.

Pronk MH, Bonsel GJ. Pronk MH, et al. Eur J Health Econ. 2004 Oct;5(3):274-7. doi: 10.1007/s10198-003-0223-0. Eur J Health Econ. 2004. PMID: 15714349

7

[Class substitution as an instrument of efficiency in the supply of medicines: possibilities and limitations].

de Smet PA, van der Kuy A, Bonsel GJ. de Smet PA, et al. Among authors: bonsel gj. Ned Tijdschr Geneeskd. 2002 Mar 23;146(12):553-7. Ned Tijdschr Geneeskd. 2002. PMID: 11938577 Dutch.

8

Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model.

van Hout BA, Wielink G, Bonsel GJ, Rutten FF. van Hout BA, et al. Among authors: bonsel gj. Pharmacoeconomics. 1993 May;3(5):387-97. doi: 10.2165/00019053-199303050-00006. Pharmacoeconomics. 1993. PMID: 10146889

9

Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries.

Janssen MF, Buchholz I, Golicki D, Bonsel GJ. Janssen MF, et al. Among authors: bonsel gj. Pharmacoeconomics. 2022 Nov;40(11):1081-1093. doi: 10.1007/s40273-022-01172-4. Epub 2022 Aug 5. Pharmacoeconomics. 2022. PMID: 35930137 Free PMC article.

10

Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries.

Janssen MF, Bonsel GJ, Luo N. Janssen MF, et al. Pharmacoeconomics. 2018 Jun;36(6):675-697. doi: 10.1007/s40273-018-0623-8. Pharmacoeconomics. 2018. PMID: 29470821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page